SKY

SKY LTD Closed Joint-Stock Company was founded in 1997 as an investment company. In 1998 , a research laboratory was created in Moscow and the necessary staff of qualified specialists was recruited. Since 2001 , the company begins to invest in promising projects in the field of medicine. The hardware - medical complex SAI-01-B, made by the method of Professor A.I. Stupko, became the first project in medicine in the treatment of chronic inflammatory diseases of the genitourinary sphere. In 2002 , several biologically active food additives based on plant materials were developed and registered. In 2003 , SKY LTD CJSC focused on investments in scientific developments in the field of molecular biology. To this end, the company works in close cooperation with leading institutes, laboratories, and clinical institutions of Russia, directing its efforts to create new drugs in the field of immunology, oncology and gynecology. In 2008 , the company registered in Russia an original drug of its own development - the immunostimulating agent Stimforte - for the treatment of herpes virus infections and furunculosis. In 2010 , the company's portfolio was replenished with a drug for the treatment of hepatitis B. In 2014 , the company registers in Belarus its own development, which has no analogues in the world, - the drug Endoferin. A year later, RUE Belmedpreparaty mastered the production of Endoferin at its production facilities. At the end of 2017 , SKY LTD CJSC starts actions aimed at registering Endoferin in Russia. The company's portfolio is constantly updated with new scientific developments based on research in the field of immunology, gynecology, oncology, infectology.